Spring Statement 2025: A summary
A summary of the announcements in Spring Statement 2025 and an overview of the latest economic forecasts.

There will be a Westminster Hall debate on the economic contribution of medicinal cannabis on Thursday 20 April 2023 at 3pm. The debate will be led by the Rt Hon David Mundell MP.
Debate pack: economic contribution of medicinal cannabis (165 KB , PDF)
There are no official estimates of the size of the medicinal cannabis industry in the UK, and unofficial estimates of the size of the sector vary widely. However, we do know that the UK is the world’s biggest producer and exporter of legal cannabis for medical and scientific purposes.
Globally there is a rising trend in the legal production and use of cannabis for medical and scientific purposes.
There are several companies operating in the UK that develop or manufacture medicinal cannabis products. These include:
Jazz Pharmaceuticals, which has offices in Oxford, Cambridge and London. Jazz produces Epidyolex and Sativex, which are licenced by the Medicines and Healthcare products Regulatory Authority (MHRA);
Celadon Pharmaceuticals, which has a manufacturing facility in Birmingham, where it grows cannabis and extracts cannabinoid active pharmaceutical ingredients, as well as carrying out research;
Target Healthcare, which makes certain Bedrocan cannabis oils in the UK;
GROW Biotech, the R&D arm of the GROW Group, which carries out research on cannabis-based products in Harpenden; and
Brown and Burk UK Ltd, which supplies Nabilone – this is a licensed medicine that contains synthetic compounds structurally related to naturally occurring cannabinoids.
Debate pack: economic contribution of medicinal cannabis (165 KB , PDF)
A summary of the announcements in Spring Statement 2025 and an overview of the latest economic forecasts.
Inflation measures the change in prices over time. Find the latest data on changes in UK consumer prices, measured by CPI and RPI.
Analysis of the latest UK and international economic indicators